Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy

por Hsu, Ching-Sheng, Hsu, Shih-Jer, Liu, Wei-Liang, Chen, Ding-Shinn, Kao, Jia-Horng
Publicado 2016

Direct comparison of biopsy techniques for hepatic malignancies

por Huang, Shang-Chin, Liang, Ja-Der, Hsu, Shih-Jer, Hong, Tzu-Chan, Yang, Hung-Chih, Kao, Jia-Horng
Publicado 2021

Microelimination of Chronic Hepatitis C by Universal Screening Plus Direct-Acting Antivirals for Incarcerated Persons in Taiwan

por Yang, Tsung-Hua, Fang, Yu-Jen, Hsu, Shih-Jer, Lee, Ji-Yuh, Chiu, Min-Chin, Yu, Jian-Jyun, Kuo, Chia-Chi, Chen, Chien-Hung
Publicado 2020

Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions

por Chou, Yi-Hong, Liang, Ja-Der, Wang, Shen-Yung, Hsu, Shih-Jer, Hu, Jui-Ting, Yang, Sien-Sing, Wang, Hsin-Kai, Lee, Tien-Ying, Tiu, Chui-Mei
Publicado 2019

High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments

por Nien, Hsiao-Ching, Hsu, Shih-Jer, Su, Tung-Hung, Yang, Po-Jen, Sheu, Jin-Chuan, Wang, Jin-Town, Chow, Lu-Ping, Chen, Chi-Ling, Kao, Jia-Horng, Yang, Wei-Shiung
Publicado 2017

Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease

por Lin, Meng-Ju, Su, Tung-Hung, Chen, Chieh-Chang, Wu, Wei-Kai, Hsu, Shih-Jer, Tseng, Tai-Chung, Liao, Sih-Han, Hong, Chun-Ming, Yang, Hung-Chih, Liu, Chun-Jen, Wu, Ming-Shiang, Kao, Jia-Horng
Publicado 2023

Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease

por Lin, Meng-Ju, Su, Tung-Hung, Chen, Chieh-Chang, Wu, Wei-Kai, Hsu, Shih-Jer, Tseng, Tai-Chung, Liao, Sih-Han, Hong, Chun-Ming, Yang, Hung-Chih, Liu, Chun-Jen, Wu, Ming-Shiang, Kao, Jia-Horng
Publicado 2023

Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B

por Huang, Yi-Wen, Hsu, Chao-Wei, Lu, Sheng-Nan, Yu, Ming-Lung, Su, Chien-Wei, Su, Wei-Wen, Chien, Rong-Nan, Hsu, Ching-Sheng, Hsu, Shih-Jer, Lai, Hsueh-Chou, Qin, Albert, Tseng, Kuan-Chiao, Chen, Pei-Jer
Publicado 2020

Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan

por Hong, Chun-Ming, Lin, You-Yu, Liu, Chun-Jen, Lai, Ya-Yun, Yeh, Shiou-Hwei, Yang, Hung-Chih, Kao, Jia-Horng, Hsu, Shih-Jer, Huang, Yi-Hsiang, Yang, Sheng-Shun, Kuo, Hsing-Tao, Cheng, Pin-Nan, Yu, Ming-Lung, Chen, Pei-Jer
Publicado 2021

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients

por Yang, Chi-Chieh, Tsai, Wei-Lun, Su, Wei-Wen, Huang, Chung-Feng, Cheng, Pin-Nan, Lo, Ching-Chu, Tseng, Kuo-Chih, Mo, Lein-Ray, Wang, Chun-Hsiang, Hsu, Shih-Jer, Lai, Hsueh-Chou, Su, Chien-Wei, Liu, Chun-Jen, Peng, Cheng-Yuan, Yu, Ming-Lung
Publicado 2015

Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy

por Lin, Hsien‐Hong, Hsu, Shih‐Jer, Lu, Sheng‐Nan, Chuang, Wan‐Long, Hsu, Chao‐Wei, Chien, Rong‐Nan, Yang, Sien‐Sing, Su, Wei‐Wen, Wu, Jaw‐Ching, Lee, Tzong‐Hsi, Peng, Cheng‐Yuan, Tseng, Kuan‐Chiao, Qin, Albert, Huang, Yi‐Wen, Chen, Pei‐Jer
Publicado 2021

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients

por Lee, Mei-Hsuan, Huang, Chung-Feng, Lai, Hsueh-Chou, Lin, Chun-Yen, Dai, Chia-Yen, Liu, Chun-Jen, Wang, Jing-Houng, Huang, Jee-Fu, Su, Wen-Pang, Yang, Hung-Chih, Kee, Kwong-Ming, Yeh, Ming-Lun, Chuang, Po-Heng, Hsu, Shih-Jer, Huang, Ching-I, Kao, Jung-Ta, Chen, Chieh-Chang, Chen, Sheng-Hung, Jeng, Wen-Juei, Yang, Hwai-I, Yuan, Yong, Lu, Sheng-Nan, Sheen, I-Shyan, Liu, Chen-Hua, Peng, Cheng-Yuan, Kao, Jia-Horng, Yu, Ming-Lung, Chuang, Wan-Long, Chen, Chien-Jen
Publicado 2017